Gene targets of antisense therapies in breast cancer

By Yang Ding Cheng   Head Jonathan F   Elliott Robert L  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 3, 2002-06 ,pp. : 375-385

Informa Healthcare

Access to resources Recommend Favorite

Treating systemic prostate cancer: emerging drug targets and therapies

By Gulley J.   Arlen P.   Dahut W.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 6, 2000-12 ,pp. : 751-763

Informa Healthcare

Access to resources Recommend Favorite

TNF-blockade in patients with advanced hormone refractory prostate cancer

By Diaz Luis   Messersmith Wells   Sokoll Lori   Sinibaldi Vicki   Moore Sandy   Carducci Michael   Eisenberger Mario  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 192-194

Springer Publishing Company

Access to resources Recommend Favorite

Targeted therapies for prostate cancer

By Asatiani Ekatherine   Gelmann Edward P  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 283-298

Informa Healthcare

Access to resources Recommend Favorite

Apoptosis-mediated Cytotoxic Effects of Ibandronic Acid on Hormone- and Drug-refractory Prostate Cancer Cells and Human Breast Cancer Cells

By Kucukzeybek Y   Gorumlu G   Cengiz E   Karabulut B   Sezgin C   Atmaca H   Sanli UA   Uzunoglu S   Uslu R  

The Journal of International Medical Research, Vol. 38, Iss. 5, 2010-09 ,pp. : 1663-1672

Field House Publishing

Access to resources Recommend Favorite